Key terms
About PMVP
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PMVP news
Apr 11
7:46pm ET
PMV Pharmaceuticals initiated with a Buy at Jefferies
Mar 27
8:10am ET
PMV Pharmaceuticals announces first patient dosed in Phase 2 PYNNACLE trial
Mar 19
7:55am ET
Oppenheimer Remains a Hold on PMV Pharmaceuticals (PMVP)
Mar 18
4:22pm ET
PMV Pharmaceuticals reports promising efficacy of rezatapopt in OC study
Mar 07
6:27am ET
PMV Pharmaceuticals: Buy Rating Affirmed Amid Strong Financials and Promising Clinical Prospects
Mar 01
7:48am ET
Oppenheimer Keeps Their Hold Rating on PMV Pharmaceuticals (PMVP)
Feb 29
6:35pm ET
TD Cowen Reaffirms Their Buy Rating on PMV Pharmaceuticals (PMVP)
Feb 29
4:14pm ET
PMV Pharmaceuticals reportsFY23 EPS ($1.44), consensus ($1.52)
Jan 18
4:09pm ET
PMV Pharmaceuticals annouces strategic 30% workforce reduction
No recent news articles are available for PMVP
No recent press releases are available for PMVP
PMVP Financials
Key terms
Ad Feedback
PMVP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PMVP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
